- Wugen to Present Correlative Data and Long-Term Follow-Up Updates for Off-the-Shelf, Allogeneic CD7-Targeted CAR-T Cell therapy at the 2025 ASH Annual Meeting
- $3.45 Bn Bioburden Testing Markets - Global Forecasts from 2025 to 2030: Opportunities Arise from Industry Expansion, Compliance Needs, and Innovation, Despite Challenges
- $26.29 Bn Biochips Markets - Forecasts from 2025 to 2030: Opportunities in Diagnostics, Drug Discovery, and Personalized Medicine, with Significant Potential in Emerging Markets
- Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview
- MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
- Annovis To Present at the 2025 Annual Meeting of the Parkinson Study Group
- Me Too Drugs Industry Research Report 2025: Market to Reach $541.86 Million by 2030, Driven by Lower R&D Risk, Therapeutic Alternatives, and Opportunities from Patent Expirations
- Nanopharmaceuticals Research Report 2025: Market to Reach $104.58 Billion by 2030, Driven by Rising Chronic Disease Burden and Growing Investment in Regenerative Medicine and Nanotechnology Drugs
- LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.
- LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.
